China Digest: Inmagene bags $21m; eWTP co-leads funding in RongCloud

Immagene Biopharmaceuticals has raised $21 million in a Series B round led by Vertex Ventures China, while RongCloud Inc garnered “tens of millions of US dollars” in a Series D round jointly led by Shenzhen Capital Group and Electronic World Trade Platform (eWTP).